Toronto Dominion Bank’s Altimmune ALT Stock Holding History

Toronto Dominion Bank’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,631	Closed	-$10K	–	1305
2022 Q1	$10K	Buy	+1,631	New	+$12K	﹤0.01%	1273

Other funds holding ALT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Toronto Dominion Bank's ALT Position: Q2 2022 in Review

Toronto Dominion Bank sold out of Altimmune (ALT) in Q2 2022, closing a stake of 1,631 shares — an estimated $10K sold.

Toronto Dominion Bank first reported a position in ALT in Q1 2022 and held it in 1 quarter. The position peaked at $10K in Q1 2022. 110 funds tracked by Wall St. Rank hold ALT as of Q2 2022.

Toronto Dominion Bank reported no remaining Altimmune position as of Q2 2022 after selling out during the quarter.
Toronto Dominion Bank sold 1,631 Altimmune shares in Q2 2022, an estimated $10K.
Toronto Dominion Bank first reported a position in Altimmune in Q1 2022 and held it in 1 quarter.
Toronto Dominion Bank's Altimmune position peaked at $10K in Q1 2022.
110 funds tracked by Wall St. Rank held Altimmune as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.